Balmer Lawrie & Company share news and announcements

NSE: BALMLAWRIEBSE: 523319DiversifiedSmall Cap

₹149.71₹2.88 (1.89%)BSE ₹149.85

Share price at the NSE close on 23 Oct 2026. Previous close ₹152.59.

52-week range of traded prices to 23 Oct 2026

₹148.00Low, 22 Oct 2026₹206.10High, 29 Oct 2025

Next results date: the board meets on 2 Nov 2026 to consider: financial results and other business matters.

Market cap: ₹2,560 Cr970th largest listed
P/E: 9.2
P/B: 1.2
Dividend yield: 5.68%
ROE: 13.8%
ROCE: 13.3%
Debt to equity: 0.04
Volume, NSE: 1,90,55261.2% delivered

Balmer Lawrie & Company board meetings

159 filed, newest first. Page 1 of 4.

Oct 2026
- 9 Oct · Board meeting
  (as amended) ( Listing Regulations ), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 2nd November, 2026 to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) for the second quarter and half year of Financial Year 2026-27 ended on 30th September, 2026 (subject to prior review by the Audit Committee of the Company).Further to our intimation dated 24th September, 2026, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons (as amended), framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider with effect from Thursday, 1st October, 2026 and shall continue to remain closed till 48 hours after the declaration of the Financial Results for the aforesaid period. (opens in a new tab)
Jul 2026
- 16 Jul · Board meeting
  Intimation of Board Meeting inter-alia, for:(a) Consideration of Unaudited Financial Results (both Standalone and Consolidated) for the first quarter of Financial Year 2026-27 ended on 30th June, 2026;(b) Closure of Trading Window (opens in a new tab)
May 2026
- 5 May · Board meeting
  Intimation of Board Meeting inter-alia, for:i. Consideration of Audited Financial Results (both Standalone and Consolidated) for the Fourth Quarter and Financial Year ended on 31st March, 2026;ii. Recommendation of Final Dividend, if any, on the Equity Shares of the Company for the Financial Year ended on 31st March, 2026;iii. Analysis/Deliberation regarding Buy back of shares, Issue of Bonus Shares and Splitting of Shares in light of evaluation of Consolidated Guidelines on general principles and mechanism for Capital Restructuring of CPSEs issued by Ministry of Finance, Department of Investment & Public Asset Management (DIPAM) (opens in a new tab)
Mar 2026
- 5 Mar · Board meeting
  Disclosure under Regulation 30 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) (as amended) Comments of Board of Directors of the Company with respect to fines imposed by BSE Limited and National Stock Exchange of India Limited on the Company on account of its non-compliance with Regulation 17(1) and Regulation 19(1)/19(2) of the Listing Regulations for the quarter ended on 31st December, 2025 (opens in a new tab)
Feb 2026
- 18 Feb · Board meeting
  Intimation of Board Meeting, inter-alia, for:(a) Consideration of payment of Interim Dividend for Financial Year 2025-26;(b) Closure of Trading Window (opens in a new tab)
Jan 2026
- 27 Jan · Board meeting
  (a) Approval of Unaudited Financial Results (both Standalone and Consolidated) for the third quarter and nine months ended on 31st December, 2025;(b) Closure of Trading Window (opens in a new tab)
Oct 2025
- 28 Oct · Board meeting
  (as amended), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 6th November 2025 to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) for the 2nd quarter and half year of FY 2025-26 ended on 30th September, 2025.Further to our intimation dated 26.09.2025, the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons , framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider with effect from Wednesday, 01.10.2025 and shall continue to remain closed till 48 hours after the declaration of the Financial Results for the said period. (opens in a new tab)
Jul 2025
- 16 Jul · Board meeting
  ( Listing Regulations ), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 6th August, 2025 to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) for the first quarter of the Financial Year 2025-26 ended on 30th June, 2025 (subject to prior review by the Audit Committee of the Company).Further to our intimation dated 25th June, 2025, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons (as amended), framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider with effect from Tuesday, 1st July, 2025 and shall continue to remain closed till 48 hours after the declaration of the Financial Results for the aforesaid period. (opens in a new tab)
Apr 2025
- 28 Apr · Board meeting
  ( Listing Regulations ), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 15th May, 2025, inter-alia, to:(a) (i) Consider the Audited Financial Results (both Standalone and Consolidated) of the Company for the Fourth Quarter and Financial Year ended on 31st March, 2025 (subject to prior review by the Audit Committee of the Company).(ii) Consider the recommendation of dividend on the Equity Shares of the Company for the Financial Year ended on 31st March, 2025, which subsequently upon declaration by the Shareholders at the ensuing Annual General Meeting would be paid to the Shareholders of the Company within 30 days from the date of such declaration.(iii) Review of the compliance of Consolidated Guidelines on general principles and mechanism for Capital Restructuring of CPSEs issued by Ministry of Finance, Department of Investment & Public Asset Management (DIPAM), in course of which, analysis/deliberation regarding Buy back of shares, issuance of Bonus Shares and splitting of shares of the Company may also take place.(b) Further to our intimation dated 24th March, 2025, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons (as amended), framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider with effect from Tuesday, 1st April, 2025 and shall continue to remain closed till 48 hours after the declaration of the Financial Results for the aforesaid period. (opens in a new tab)
Feb 2025
- 10 Feb · Board meeting
  Outcome of Board meeting held on 10th February, 2025 (opens in a new tab)
- 10 Feb · Board meeting
  Outcome of Board Meeting held on 10th February, 2025. (opens in a new tab)
Jan 2025
- 21 Jan · Board meeting
  Intimation of Board Meeting, inter-alia, for:(a) Approval of Unaudited Financial Results (both Standalone and Consolidated) for the third quarter and nine months ended on 31st December, 2024;(b) Closure of Trading Window (opens in a new tab)
- 7 Jan · Board meeting
  Outcome of Board Meeting held on January 07, 2025. (opens in a new tab)
Nov 2024
- 5 Nov · Board meeting
  Outcome of Board Meeting held on 5th November, 2024 (opens in a new tab)
- 5 Nov · Board meeting
  Outcome of Board meeting held on 5th November, 2024 (opens in a new tab)
Oct 2024
- 29 Oct · Board meeting
  Approval of Unaudited Financial Results (both Standalone and Consolidated) for the second quarter and half year ended on 30th September, 2024 (opens in a new tab)
Aug 2024
- 12 Aug · Board meeting
  Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015- Outcome of Board Meeting held on 12th August, 2024 (opens in a new tab)
Jul 2024
- 29 Jul · Board meeting
  Outcome of Board Meeting held on July 29, 2024. (opens in a new tab)
- 29 Jul · Board meeting
  Outcome of Board meeting dated 29.07.2024 (opens in a new tab)
- 15 Jul · Board meeting
  ( Listing Regulations ), it is hereby informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Monday, 29th July, 2024 to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) of the first quarter of the Financial Year 2024-25 ended on 30th June, 2024 (subject to prior review by the Audit Committee of the Company).Further to our intimation dated 26th June, 2024, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons , framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider w.e.f. Monday, 1st July, 2024 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results. (opens in a new tab)
May 2024
- 24 May · Board meeting
  Outcome of Board Meeting dated 24th May, 2024 (opens in a new tab)
- 6 May · Board meeting
  Review of the compliance of Guidelines on Capital Restructuring of Central Public Sector Enterprises (CPSEs) by Ministry of Finance, Department of Investment & Public Asset Management (DIPAM), in course of which, analysis/deliberation regarding Buy back of shares, issuance of Bonus Shares and splitting of shares of the Company may also take place. (opens in a new tab)
Feb 2024
- 8 Feb · Board meeting
  Outcome of Board Meeting held on February 08, 2024. (opens in a new tab)
- 8 Feb · Board meeting
  Disclosure under Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) (opens in a new tab)
Jan 2024
- 11 Jan · Board meeting
  ( Listing Regulations ), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 8th February, 2024 to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) of the Company for the third quarter and nine months ended on 31st December, 2023 (subject to prior review by the Audit Committee of the Company).In furtherance to our intimation dated 21st December, 2023, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons (as amended), framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their Immediate Relatives and Insider w.e.f. Monday, 1st January, 2024 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results. (opens in a new tab)
Nov 2023
- 7 Nov · Board meeting
  1. Disclosure under Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Approval of Unaudited Financial Results (both Standalone and Consolidated) for the Second Quarter and Half -Year ended on 30th September, 20232. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) with respect to the appointment of Statutory Auditors and Branch Auditors for the Financial Year 2023-24 (opens in a new tab)
- 7 Nov · Board meeting
  1. Disclosure under Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Approval of Unaudited Financial Results (both Standalone and Consolidated) for the Second Quarter and Half -Year ended on 30th September, 20232. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) with respect to the appointment of Statutory Auditors and Branch Auditors for the Financial Year 2023-24 (opens in a new tab)
Oct 2023
- 11 Oct · Board meeting
  (as amended), ( Listing Regulations ), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 7rd November, 2023, to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) of the Company for the second quarter/ half year ended on 30th September, 2023 (subject to prior review by the Audit Committee of the Company).In furtherance to our intimation dated 29th September, 2023, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons (as amended) framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their Immediate Relatives and Insider with effect from Sunday, 1st October, 2023 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results.The said notice shall be available on the website of the Company at: www.balmerlawrie.com. (opens in a new tab)
Aug 2023
- 7 Aug · Board meeting
  Outcome of Board Meeting held on August 07, 2023.-Disclosure under Regulation 30 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Appointment of Internal Auditor for a period of three Financial years from 2023-24 to 2025-26-Disclosure under Regulation 30 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) Approval for Procurement of Locking Rings for all units of SBU Industrial Packaging from M/s. Balmer Lawrie Van Leer Limited (BLVL), Bangalore- a Joint Venture of M/s. Balmer Lawrie & Co. Ltd.-a) Outcome of the Board Meeting:1. Fixation of date of 106th Annual General Meeting ( AGM ) and approval of draft Notice of AGM2. Cut-off dates for despatch of Notice for 106th AGM and Annual Report to the Members3. Schedule of e-voting and Cut-off date for e-voting4. Approval of Board s Report along with Annexures thereto5. Appointment of Scrutinizer for 106th AGM6. Closure of Register of Members and the Share Transfer Books of the Company for the purpose of dividend, if declared at the AGMb) Dividend pay-out date and cut-off date for payment of dividend, if declared at the AGM-Disclosure under Regulation 30 & 33 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Approval of Unaudited Financial Results (both Standalone and Consolidated) for the First Quarter ended on 30th June, 2023 (opens in a new tab)
- 7 Aug · Board meeting
  Board meeting held on August 07, 2023.-Disclosure under Regulation 30 & 33 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Approval of Unaudited Financial Results (both Standalone and Consolidated) for the First Quarter ended on 30th June, 2023-a) Outcome of the Board Meeting:1. Fixation of date of 106th Annual General Meeting ( AGM ) and approval of draft Notice of AGM2. Cut-off dates for despatch of Notice for 106th AGM and Annual Report to the Members3. Schedule of e-voting and Cut-off date for e-voting4. Approval of Board s Report along with Annexures thereto5. Appointment of Scrutinizer for 106th AGM6. Closure of Register of Members and the Share Transfer Books of the Company for the purpose of dividend, if declared at the AGMb) Dividend pay-out date and cut-off date for payment of dividend, if declared at the AGM-Disclosure under Regulation 30 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) Approval for Procurement of Locking Rings for all units of SBU Industrial Packaging from M/s. Balmer Lawrie Van Leer Limited (BLVL), Bangalore- a Joint Venture of M/s. Balmer Lawrie & Co. Ltd.-Disclosure under Regulation 30 of Securities and Exchange Board of India ( SEBI ) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Appointment of Internal Auditor for a period of three Financial years from 2023-24 to 2025-26 (opens in a new tab)
Jul 2023
- 27 Jul · Board meeting
  Meeting on 7 Aug 2023: “BALMER LAWRIE & COMPANY LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period” (opens in a new tab)
- 19 Jul · Board meeting
  (a) Intimation of Board Meeting, inter-alia for:i. Approval of Unaudited Financial Results (both Standalone and Consolidated) for the first quarter of Financial Year 2023-24 ended on 30th June, 2023;ii. Book Closure and other matters related to 106th Annual General Meeting ( AGM ) for 2023 (b) Closure of Trading Window (opens in a new tab)
May 2023
- 25 May · Board meeting
  Outcome of Board Meeting held on May 25, 2023.1. Disclosure under Regulation 30 and Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) Audited Financial Results (both Standalone and Consolidated) for the quarter/year ended March 31, 20232. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Decision of the Board of Directors not to recommend the issue of Bonus Shares3. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Decision of the Board of Directors to not Buy back the shares of the Company4. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Recommendation of Dividend for the Financial Year ended on 31st March, 2023 (opens in a new tab)
- 25 May · Board meeting
  1. Disclosure under Regulation 30 and Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) Audited Financial Results (both Standalone and Consolidated) for the quarter/year ended March 31, 20232. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Recommendation of Dividend for the Financial Year ended on 31st March, 20233. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Decision of the Board of Directors not to recommend the issue of Bonus Shares4. Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Decision of the Board of Directors to not Buy back the shares of the Company (opens in a new tab)
Apr 2023
- 26 Apr · Board meeting
  ( Listing Regulations ), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 25th May, 2023, inter-alia, to:i. Consider the Audited Financial Results (both Standalone and Consolidated) of the Company for the Fourth Quarter and Financial Year ended on 31st March, 2023 (subject to prior review by the Audit Committee of the Company).ii. Consider the recommendation of dividend on the Equity Shares of the Company for the Financial Year ended on 31st March, 2023, if any, which subsequently upon declaration by the Shareholders at the ensuing Annual General Meeting would be paid to the Shareholders of the Company within 30 days from the date of such declaration.Further to our intimation dated 30th March, 2023, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons , framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider with effect from Saturday, 1st April, 2023 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results and the information becomes generally available. (opens in a new tab)
Feb 2023
- 10 Feb · Board meeting
  Outcome of Board Meeting held on February 10, 2023. (opens in a new tab)
Jan 2023
- 13 Jan · Board meeting
  ( Listing Regulations ), this is to hereby inform that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 10th February, 2023 to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) of the Company for the third quarter and nine months ended on 31st December, 2022 (subject to prior review by the Audit Committee of the Company).In furtherance to our intimation dated 26th December, 2022, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons , framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their Immediate Relatives and Insider w.e.f. Sunday, 1st January, 2023 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results.The said notice shall be available on the website of the Company at: www.balmerlawrie.com. (opens in a new tab)
Oct 2022
- 19 Oct · Board meeting
  ( Listing Regulations), it is hereby informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 3rd November, 2022, to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone and Consolidated) of the Company for the second quarter/ half year ended on 30th September, 2022 (subject to prior review by the Audit Committee of the Company).In furtherance to our intimation dated 24th September, 2022, it may be noted that as per the Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons, framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended), the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider w.e.f. Saturday, 1st October, 2022 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results and the information becomes generally available. (opens in a new tab)
Aug 2022
- 5 Aug · Board meeting
  Board Meeting held on 05-Aug-2022 to consider Other business matters (opens in a new tab)
- 5 Aug · Board meeting
  Board Meeting held on 05-Aug-2022 to consider financial statements for the period ended June 2022 (opens in a new tab)
Jul 2022
- 28 Jul · Board meeting
  Board Meeting to be held on 05-Aug-2022 to consider financial statements for the period ended June 2022, Dividend and Other business matters (opens in a new tab)
May 2022
- 27 May · Board meeting
  Further, to our intimation dated 11th May, 2022 and pursuant to Regulation 30 and Regulation 33 read with Schedule III of the Listing Regulations, this is to hereby inform that the Board at its Meeting held on 27th May, 2022 has, inter-alia, approved the following, which are attached for your records:1. The Audited Financial Results (both Standalone and Consolidated) of the Company for the fourth quarter and Financial Year ended on 31st March, 2022, as recommended by the Audit Committee;2. The Audited Financial Statement (both Standalone and Consolidated) of the Company for the Financial Year ended 31st March, 2022, as recommended by the Audit Committee;3. Declaration of unmodified opinion with respect to the Statutory Auditor's Report on the Annual Audited Financial Results (both Standalone and Consolidated) of the Company for Financial Year ended on 31st March, 2022;4. The Statement of Assets and Liabilities (both Standalone and Consolidated) as on 31st March, 2022;5. The Statement of Cash Flows (both Standalone and Consolidated) for the Financial Year ended on 31st March, 2022;6. The Auditor's Report (for both Standalone and Consolidated) of the Company for the Financial Year ended on 31st March, 2022; 7. CEO/CFO certification (both Standalone and Consolidated) of the Company for the fourth quarter and Financial Year ended on 31st March, 2022.8. CEO and CFO Compliance certificate.The Audited Financial Results (both Standalone and Consolidated) shall be published in the newspapers as per Regulation 47(1) of the Listing Regulations and would be also available on the website of the Company at www.balmerlawrie.com. (opens in a new tab)
- 11 May · Board meeting
  Board Meeting to be held on 27-May-2022 to consider financial statements for the period ended March 2022, Dividend and Other business matters.In terms of Regulation 29 of the Securities and Exchange Board of India ( SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015, ( Listing Regulations), it is hereby informed that a Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 27th May, 2022, inter-alia, to:i. Consider and approve the Audited Financial Results (both Standalone and Consolidated) of the Company for the Fourth Quarter and Financial Year ended on 31st March, 2022 (subject to prior review by the Audit Committee of the Company).ii. Consider the recommendation of dividend on the Equity Shares of the Company for the Financial Year ended on 31st March, 2022, if any, which subsequently upon declaration by the Shareholders at the ensuing Annual General Meeting would be paid to the Shareholders of the Company within 30 days from the date of such declaration. (opens in a new tab)
Feb 2022
- 9 Feb · Board meeting
  Further, to our intimation dated 21st January, 2022 and in terms of Regulation 30 read with Schedule III, Part A and Regulation 33 of the Listing Regulations, we hereby inform you that the Board of Directors at its Meeting held on 9th February, 2022 has, inter-alia, considered and approved the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the third quarter and nine months ended on 31st December, 2021 along with the Limited Review Report of the Statutory Auditors thereon. The Unaudited Financial Results shall be published in the newspapers as per Regulation 47(1) of the Listing Regulations and would also be uploaded on the website of the Company at www.balmerlawrie.com as per Regulation 46(2) of the Listing Regulations. (opens in a new tab)
- 9 Feb · Board meeting
  Further, to our intimation dated 21st January, 2022 and in terms of Regulation 30 read with Schedule III, Part A and Regulation 33 of the Listing Regulations, we hereby inform you that the Board of Directors at its Meeting held on 9th February, 2022 has, inter-alia, considered and approved the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the third quarter and nine months ended on 31st December, 2021 along with the Limited Review Report of the Statutory Auditors thereon. The Unaudited Financial Results shall be published in the newspapers as per Regulation 47(1) of the Listing Regulations and would also be uploaded on the website of the Company at www.balmerlawrie.com as per Regulation 46(2) of the Listing Regulations. (opens in a new tab)
Jan 2022
- 21 Jan · Board meeting
  ( Listing Regulations ), it is hereby informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 9th February, 2022, to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone & Consolidated) of the Company for the third quarter and nine months ended on 31st December, 2021 (subject to prior review by the Audit Committee of the Company).In furtherance to our intimation dated 28th December, 2021, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relative of Designated Persons , framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider w.e.f. Saturday, 1st January, 2022 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results and the information becomes generally available. (opens in a new tab)
Nov 2021
- 10 Nov · Board meeting
  Disclosure under Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ) - Approval of Unaudited Financial Results (both Standalone and Consolidated) for the Second Quarter and Half -Year ended on 30th September, 2021 Further, to our intimation dated 28th October, 2021 and in terms of Regulation 30 read with Schedule III, Part A and Regulation 33 of the Listing Regulations, we hereby inform you that the Board of Directors at its Meeting held on 10th November, 2021 has, inter-alia, considered and approved the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the second quarter and half-year ended on 30th September, 2021 along with the Limited Review Report of the Statutory Auditors thereon. The Unaudited Financial Results shall be published in the newspapers as per Regulation 47(1) of the Listing Regulations and would also be uploaded on the website of the Company at www.balmerlawrie.com as per Regulation 46(2) of the Listing Regulations. (opens in a new tab)
Oct 2021
- 28 Oct · Board meeting
  ( Listing Regulations ), it is hereby informed that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 10th November, 2021, to, inter-alia, consider the approval of Unaudited Financial Results (both Standalone & Consolidated) of the Company for the second quarter/ half year ended on 30th September, 2021 (subject to prior review by the Audit Committee of the Company).In furtherance to our intimation dated 28th September, 2021, it may be noted that as per the Company s Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and Immediate Relatives of Designated Persons , framed pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015, (as amended) the Trading Window of the Company which has already been closed for Designated Persons and their immediate relatives and Insider w.e.f. Friday, 1st October, 2021 shall continue to remain closed till 48 hours after the declaration of the aforementioned Financial Results and the information becomes generally available. (opens in a new tab)
Aug 2021
- 6 Aug · Board meeting
  Outcome of Board Meeting held on August 06, 2021. (opens in a new tab)
- 6 Aug · Board meeting
  Board meeting held on August 06, 2021. (opens in a new tab)

Balmer Lawrie & Company board meetings

Oct 2026

Jul 2026

May 2026

Mar 2026

Feb 2026

Jan 2026

Oct 2025

Jul 2025

Apr 2025

Feb 2025

Jan 2025

Nov 2024

Oct 2024

Aug 2024

Jul 2024

May 2024

Feb 2024

Jan 2024

Nov 2023

Oct 2023

Aug 2023

Jul 2023

May 2023

Apr 2023

Feb 2023

Jan 2023

Oct 2022

Aug 2022

Jul 2022

May 2022

Feb 2022

Jan 2022

Nov 2021

Oct 2021

Aug 2021